Effect of statin treatment on three-month outcomes in patients with stroke-associated infection: A prospective cohort study

European Journal of Neurology

Volumn 19, Issue 5, 2012, Pages 689-695

  Yeh, P S ^a,b   Lin, H J ^a,b   Chen, P S ^c   Lin, S H ^c   Wang, W M ^c   Yang, C M ^a,b   Li, Y H ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Acute ischaemic stroke; Infection; Mortality; Statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CELL COUNT; COHORT STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFECTION; KAPLAN-MEIER ESTIMATE; LEUKOCYTES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS;

EID: 84859817929     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03608.x     Document Type: Article

References (22)

1. Langhorne P, Stott DJ, Robertson L, et al. Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223-1229.
2. Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007; 38: 1097-1103.
3. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7: 341-353.
4. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 620-625.
5. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR; GAIN International Steering Committee and Investigators. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004; 11: 49-53.
6. Vermeij FH, Scholte op Reimer WJ, de Man P, et al. ; Netherlands Stroke Survey Investigators Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009; 27: 465-471.
7. van de Beek D, Wijdicks EF, Vermeij FH, et al. Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol 2009; 66: 1076-1081.
8. Fernandez R, De Pedro VJ, Artigas A. Statin therapy prior to ICU admission: protection against infection or a severity marker? Intensive Care Med 2006; 32: 160-164.
9. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006; 367: 413-418.
10. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121: 1002-1007.
11. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29, 900 patients. Arch Intern Med 2008; 168: 2081-2087.
12. Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 2009; 169: 1658-1667.
13. Yeh PS, Lin HJ, Bai CH, et al. Effect of in-hospital initiation of lipid-lowering therapy on six-month outcomes in patients with acute ischemic stroke or transient ischemic attack. Am J Cardiol 2010; 105: 1490-1494.
14. Adams RJ, Albers G, Alberts MJ, et al. ; American Heart Association, American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008; 39: 1647-1652.
15. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
16. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35: 1941-1945.
17. Chalmers JD, Short PM, Mandal P, Akram AR, Hill AT. Statins in community acquired pneumonia: evidence from experimental and clinical studies. Respir Med 2010; 104: 1081-1091.
18. Majumdar SR, McAllister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333: 999.
19. Yang KC, Chien JY, Tseng WK. Statins do not improve short term survival in an oriental population with sepsis. Am J Emerg Med 2007; 25: 494-501.
20. Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 1545-1550.
21. Montaner J, Chacón P, Krupinski J, et al. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol 2008; 15: 82-90.
22. Rodríguez de Antonio LA, Martínez-Sánchez P, Martínez-Martínez MM, et al. Previous statins treatment and risk of post-stroke infections. Neurologia 2011; 26: 150-156.